Miranda P. Steenbeek
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Additional sectioning and AI-assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA1/2 carriers.
Journal: Histopathology
Published: May 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods study.
Journal: American journal of obstetrics and gynecology
Published: March 12, 2026
International trends in concurrent hysterectomy at risk-reducing surgery in BRCA1/2 pathogenic variant carriers: a mixed-methods study.
Journal: American journal of obstetrics and gynecology
Published: March 12, 2026
Recommendations for the use of CanRisk for tubo-ovarian cancer risk estimation: a focus group and Research ANd Development-modified Delphi-based study.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: March 03, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.
Journal: NPJ breast cancer
Published: February 25, 2026
Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy.
Journal: JAMA network open
Published: February 02, 2026
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma: The European Society of Gynaecological Oncology Consensus Statements.
Journal: JAMA
Published: February 02, 2026
Menopause-related quality of life five years after salpingectomy with delayed oophorectomy versus Salpingo-Oophorectomy.
Journal: Journal of the National Cancer Institute
Published: December 15, 2025
Menopause-related quality of life 5 years after salpingectomy with delayed oophorectomy vs salpingo-oophorectomy.
Journal: Journal of the National Cancer Institute
Published: December 15, 2025
Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study.
Journal: Maturitas
Published: August 12, 2025
Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution.
Journal: American journal of obstetrics and gynecology
Published: August 07, 2025
Pathogenesis of peritoneal high-grade serous carcinoma after risk-reducing surgery: a systematic review.
Journal: The journal of pathology. Clinical research
Published: April 07, 2025
Last Updated: 09/26/2026